MML Investors Services’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
PL
OAM
EGA
LWAM
MML Investors Services's GMAB Position: Q2 2026 in Review
MML Investors Services increased its Genmab (GMAB) stake by 46% in Q2 2026, buying an estimated $471K and bringing the position to 55,948 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #1732.
MML Investors Services first reported a position in GMAB in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.43M in Q1 2024. 135 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.
- MML Investors Services held 55,948 shares of Genmab worth $1.54M as of Q2 2026.
- MML Investors Services bought 17,718 Genmab shares in Q2 2026, an estimated $471K.
- Genmab made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #1732 holding.
- MML Investors Services first reported a position in Genmab in Q2 2020 and has held it in 25 quarters since.
- MML Investors Services's Genmab position peaked at $2.43M in Q1 2024.
- 135 funds tracked by Wall St. Rank held Genmab as of Q2 2026.
Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.